Yaojin Peng

733 total citations
17 papers, 171 citations indexed

About

Yaojin Peng is a scholar working on Molecular Biology, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yaojin Peng has authored 17 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Physiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yaojin Peng's work include Biomedical Ethics and Regulation (9 papers), Pluripotent Stem Cells Research (6 papers) and CRISPR and Genetic Engineering (6 papers). Yaojin Peng is often cited by papers focused on Biomedical Ethics and Regulation (9 papers), Pluripotent Stem Cells Research (6 papers) and CRISPR and Genetic Engineering (6 papers). Yaojin Peng collaborates with scholars based in China, Netherlands and India. Yaojin Peng's co-authors include Yan Zhong, Li Gao, Qi Zhou, Zhenyu Xiao, Xiao‐Ru Huang, Lulu Ding, Zhenyu Xiao, Moshi Song, Guang‐Hui Liu and Yeyang Su and has published in prestigious journals such as Nature Genetics, Nature Biotechnology and Cell stem cell.

In The Last Decade

Yaojin Peng

17 papers receiving 167 citations

Peers

Yaojin Peng
Konstantin Drexler Germany
Rashi Srivastava India
Neeraj Kumar India
Yining Xu China
A. Jomard France
Yik-Lam Cho Singapore
Khodadad Khodadadi Australia
Maartje A. E. Nieuwenhuis Netherlands
Konstantin Drexler Germany
Yaojin Peng
Citations per year, relative to Yaojin Peng Yaojin Peng (= 1×) peers Konstantin Drexler

Countries citing papers authored by Yaojin Peng

Since Specialization
Citations

This map shows the geographic impact of Yaojin Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaojin Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaojin Peng more than expected).

Fields of papers citing papers by Yaojin Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaojin Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaojin Peng. The network helps show where Yaojin Peng may publish in the future.

Co-authorship network of co-authors of Yaojin Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yaojin Peng. A scholar is included among the top collaborators of Yaojin Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaojin Peng. Yaojin Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Peng, Yaojin, et al.. (2025). Governance of cross-border genomic data sharing through a human rights approach. Nature Genetics. 57(9). 2090–2098. 1 indexed citations
2.
Peng, Yaojin, et al.. (2024). Ethical concerns in aging research: perspectives of global frontline researchers. Science China Life Sciences. 67(10). 2149–2156. 6 indexed citations
3.
Peng, Yaojin, et al.. (2024). Cooperation and Production Strategy of Power Battery for New Energy Vehicles Under Carbon Cap-and-Trade Policy. Sustainability. 16(22). 9860–9860. 2 indexed citations
4.
Chen, Luxia, et al.. (2023). The variability of judicial decisions in the stem cell industry in China. Cell stem cell. 30(10). 1294–1298. 1 indexed citations
5.
Peng, Yaojin, et al.. (2023). Acting on ethics and governance of aging research. Trends in Molecular Medicine. 29(6). 419–421. 10 indexed citations
6.
Peng, Yaojin, et al.. (2022). A framework for the responsible reform of the 14-day rule in human embryo research. Protein & Cell. 13(8). 552–558. 7 indexed citations
7.
Xiao, Zhenyu, et al.. (2022). Knowledge graphs of ethical concerns of cerebral organoids. Cell Proliferation. 55(8). e13239–e13239. 18 indexed citations
8.
Peng, Yaojin, et al.. (2022). Responsible governance of human germline genome editing in China. Biology of Reproduction. 107(1). 261–268. 11 indexed citations
9.
Cao, Jiani, Jie Hao, Lei Wang, et al.. (2021). Developing Standards to Support the Clinical Translation of Stem Cells. Stem Cells Translational Medicine. 10(S2). S85–S95. 15 indexed citations
10.
Peng, Yaojin, Xiao‐Ru Huang, & Qi Zhou. (2020). Ethical and Policy Considerations for Human Embryo and Stem Cell Research in China. Cell stem cell. 27(4). 511–514. 17 indexed citations
11.
Su, Yeyang, et al.. (2020). Stem cell ‘therapy’ advertisements in China: Infodemic, regulations and recommendations. Cell Proliferation. 53(12). e12937–e12937. 11 indexed citations
12.
Zou, Hui, Xiaozheng Cao, Qiao Xiao, et al.. (2016). Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line. Oncology Reports. 36(3). 1731–1738. 13 indexed citations
13.
Peng, Yaojin. (2016). The morality and ethics governing CRISPR–Cas9 patents in China. Nature Biotechnology. 34(6). 616–618. 12 indexed citations
14.
Peng, Yaojin, Yan Zhong, & Li Gao. (2016). Tubeimoside-1 suppresses breast cancer metastasis through downregulation of CXCR4 chemokine receptor expression. BMB Reports. 49(9). 502–507. 39 indexed citations
15.
Peng, Yaojin. (2016). The patentability of human embryonic stem cell technology in China. Nature Biotechnology. 34(1). 37–39. 5 indexed citations
16.
Peng, Yaojin. (2012). Analysis on the Clinical Efficacy of Three Internal Fixations on 82 Patients with Patella Fracture Treated. 1 indexed citations
17.
Peng, Yaojin, et al.. (2010). Expression and clinical significance of VEGF, MMP-2 and MMP-9 in ovarian carcinoma.. Xiandai shengwu yixue jinzhan. 10(12). 2322–2324. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konstantin Drexler Breakdown of academic impact, for papers by Rashi Srivastava Breakdown of academic impact, for papers by Neeraj Kumar Breakdown of academic impact, for papers by Yining Xu Breakdown of academic impact, for papers by A. Jomard Breakdown of academic impact, for papers by Yik-Lam Cho Breakdown of academic impact, for papers by Khodadad Khodadadi Breakdown of academic impact, for papers by Maartje A. E. Nieuwenhuis
Rankless by CCL
2026